Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.

Meléndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL.

Hypertension. 2010 Aug;56(2):225-31. doi: 10.1161/HYPERTENSIONAHA.109.148635. Epub 2010 Jul 6.

2.

Chronic beta-adrenoreceptor activation increases cardiac cavity size through chamber remodeling and not via modifications in myocardial material properties.

Gibbs M, Veliotes DG, Anamourlis C, Badenhorst D, Osadchii O, Norton GR, Woodiwiss AJ.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2762-7. Epub 2004 Aug 19.

3.

Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.

Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE.

J Am Coll Cardiol. 2002 Feb 20;39(4):664-71.

4.

Temporal alterations in cardiac fibroblast function following induction of pressure overload.

Stewart JA Jr, Massey EP, Fix C, Zhu J, Goldsmith EC, Carver W.

Cell Tissue Res. 2010 Apr;340(1):117-26. doi: 10.1007/s00441-010-0943-2. Epub 2010 Mar 9.

5.

Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.

Hutchinson KR, Saripalli C, Chung CS, Granzier H.

J Mol Cell Cardiol. 2015 Feb;79:104-14. doi: 10.1016/j.yjmcc.2014.10.020. Epub 2014 Nov 8.

6.

N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.

Liu YH, D'Ambrosio M, Liao TD, Peng H, Rhaleb NE, Sharma U, André S, Gabius HJ, Carretero OA.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H404-12. doi: 10.1152/ajpheart.00747.2008. Epub 2008 Dec 19.

7.

Exposure to diesel exhaust particulates induces cardiac dysfunction and remodeling.

Bradley JM, Cryar KA, El Hajj MC, El Hajj EC, Gardner JD.

J Appl Physiol (1985). 2013 Oct 1;115(7):1099-106. doi: 10.1152/japplphysiol.00343.2013. Epub 2013 Jul 25.

8.

Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.

Zheng XX, Li XY, Lyu YN, He YY, Wan WG, Zhu HL, Jiang XJ.

Exp Physiol. 2016 Feb;101(2):260-71. doi: 10.1113/EP085302. Epub 2015 Dec 16.

PMID:
26556551
9.

Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.

Ambale Venkatesh B, Volpe GJ, Donekal S, Mewton N, Liu CY, Shea S, Liu K, Burke G, Wu C, Bluemke DA, Lima JA.

Hypertension. 2014 Sep;64(3):508-15. doi: 10.1161/HYPERTENSIONAHA.114.03697. Epub 2014 Jun 9.

10.

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.

Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T.

Circulation. 2002 Jul 2;106(1):130-5.

11.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

12.

Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.

Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ.

J Am Coll Cardiol. 2007 Feb 20;49(7):811-21. Epub 2007 Feb 5.

13.

Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.

Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, Yao T, Zhu YC.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2093-100. Epub 2007 Jul 13.

14.

Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia.

Chen L, Zhang J, Gan TX, Chen-Izu Y, Hasday JD, Karmazyn M, Balke CW, Scharf SM.

J Appl Physiol (1985). 2008 Jan;104(1):218-23. Epub 2007 Nov 15.

15.

Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.

Osadchii O, Norton G, Deftereos D, Woodiwiss A.

Pharmacol Res. 2007 Apr;55(4):287-94. Epub 2006 Dec 28.

PMID:
17257851
16.

A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.

López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2372-82. doi: 10.1152/ajpheart.00283.2011. Epub 2011 Sep 16.

17.

Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats.

Badenhorst D, Maseko M, Tsotetsi OJ, Naidoo A, Brooksbank R, Norton GR, Woodiwiss AJ.

Cardiovasc Res. 2003 Mar;57(3):632-41.

PMID:
12618225
18.

Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.

Wang Y, Wu Y, Chen J, Zhao S, Li H.

Cardiology. 2013;126(1):1-11. doi: 10.1159/000351179. Epub 2013 Jul 2.

PMID:
23839341
19.

Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes.

Riva E, Andreoni G, Bianchi R, Latini R, Luvarà G, Jeremic G, Traquandi C, Tuccinardi L.

Pharmacol Res. 1998 Mar;37(3):233-40.

PMID:
9602473
20.

Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.

Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.

J Cardiovasc Pharmacol. 1999 Mar;33(3):433-9.

PMID:
10069680

Supplemental Content

Support Center